FDA — authorised 22 April 2024
- Application: BLA761336
- Marketing authorisation holder: ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
- Status: approved
FDA authorised Anktiva on 22 April 2024
Yes. FDA authorised it on 22 April 2024; FDA has authorised it.
ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU holds the US marketing authorisation.